Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation.
Saved in:
| Title: | Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation. |
|---|---|
| Authors: | Chin S; Department of Gastroenterology, Royal Prince Alfred Hospital, Sydney, Australia.; Department of Gastroenterology, Austin Health, Melbourne, Australia., Con D; Department of Gastroenterology, Austin Health, Melbourne, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia., Hilley P; Department of Gastroenterology, Austin Health, Melbourne, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia., Corte C; Department of Gastroenterology, Royal Prince Alfred Hospital, Sydney, Australia.; University of Sydney, Sydney, Australia., Liu K; Department of Gastroenterology, Royal Prince Alfred Hospital, Sydney, Australia.; University of Sydney, Sydney, Australia., Testro A; Department of Gastroenterology, Austin Health, Melbourne, Australia.; The Australian Centre for Transplantation Excellence and Research, Austin Health, Melbourne, Australia.; The Department of Surgery (Austin Precinct), The University of Melbourne, Melbourne, Australia., De Cruz P; Department of Gastroenterology, Austin Health, Melbourne, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia., Choy MC; Department of Gastroenterology, Austin Health, Melbourne, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia., Srinivasan A; Department of Gastroenterology, Austin Health, Melbourne, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia.; Eastern Health Clinical School, Monash University, Clayton, Australia. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2025 Nov; Vol. 62 (10), pp. 1003-1011. Date of Electronic Publication: 2025 Jul 15. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2036 |
|---|---|
| DOI: | 10.1111/apt.70283 |
